Viewing Study NCT05523661

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:09 PM
Ignite Modification Date: 2026-01-25 @ 7:09 AM
Study NCT ID: NCT05523661
Status: UNKNOWN
Last Update Posted: 2023-11-28
First Post: 2021-11-14
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Dasatinib Plus Anti-CD19/CD22 Bispecific CAR-T Cell Therapy for Elderly Ph-positive ALL Patients
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ph Positive ALL View
None CAR-T Cell View
None Dasatinib View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CD19/CD22 Bispecific CAR-T View
None Ph-positive lymphoblastic leukemia View
None Dasatinib View